PhRMA Foundation/LinkedIn
May 10, 2026, 09:43
New Research Targets Immune Pathways Behind Blood Clots in APS – PhRMA Foundation
PhRMA Foundation shared a post on LinkedIn:
“In antiphospholipid syndrome (APS), harmful antibodies trigger blood clots and inflammation – sometimes even when patients are on blood thinners. PhF26 awardee Thalia Newman of the University of Michigan is targeting the immune pathways behind this process to reduce risk of blood clots in APS.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
May 10, 2026, 09:47Oluyemisi Famuyiwa: Fertility Is Personal, and Informed Decisions Matter – My New Book Is Officialy Out
-
May 10, 2026, 09:39Fabian Conejo: Why Accurate Lupus Anticoagulant Testing Can Save Lives
-
May 10, 2026, 09:36Julie Lee: Emotional Impact of Miscarriage and Baby Loss
-
May 10, 2026, 08:16Your Donation Can Help Transform APS Diagnosis and Treatment – APS Foundation of America
-
May 10, 2026, 08:15Joseph Shaw: Safer Perioperative Anticoagulation Strategies in Thrombotic APS
-
May 10, 2026, 08:13Lauren Blandin: The Role of Nervous System Regulation in Fertility Treatment
-
May 10, 2026, 08:09Abhishek Saxena: Would You Trust Spermbot-Assisted Fertilization in Clinical Practice?
-
May 10, 2026, 08:06A Lower Anti-Müllerian Hormone Result Isn’t the End – Fertility Plus
-
May 10, 2026, 06:19Ronald Feinberg: AI-Powered STAR System Could Transform Azoospermia Treatment